Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin effects on eye gaze and trait autism
NCT03293511Unknown
- Sponsor
- University of Electronic Science and Technology of China
- Start
- Jun 2017
- Primary completion
- Jul 2019
- Countries
- 1
01
Overview
Randomised, double-blind trial of oxytocin nasal spray in Autism Spectrum Disorder (ASD) (2 arms), sponsored by University of Electronic Science and Technology of China. Primary endpoints: Global eye gaze characteristic: differences between oxytocin and placebo treatment and Feature-specific eye gaze characteristics: differences between oxytocin and placebo treatment. Status: unknown.
02
Drugs
oxytocin nasal spray
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT03293511.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03293511.